Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Cardiac delayed rectifier potassium channels are a group of voltage-gated potassium channels critical for mediating outward potassium currents during the plateau and repolarization phases of the cardiac action potential, thereby controlling action potential duration and the refractory period in cardiomyocytes. The main subtypes are the rapidly activating IKr (Kv11.1/hERG), slowly activating IKs (KCNQ1/KCNE1), and the atrial-specific IKur (Kv1.5). They are essential determinants of cardiac repolarization, and disruption—either by genetic mutation or drug-induced blockade—can lead to serious arrhythmias including long QT syndrome and sudden cardiac death. Clinically, these channels are targeted by several antiarrhythmic drugs but are also commonly implicated in drug-induced arrhythmias.
Channel blockade prolonging action potential duration (antiarrhythmic); Channel activation increasing repolarization to correct prolonged QT (experimental/novel approach)
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Cardiac delayed rectifier potassium channel.